VANFLYTA 17.7 mg, Filmtabletten

7680697100028 CH-69710 Filmtabletten

Associated product:

VANFLYTA cpr pell 17.7 mg 28 pce
VANFLYTA 17.7 mg, Filmtabletten
VANFLYTA 17.7 mg, Filmtabletten
VANFLYTA 17.7 mg, Filmtabletten
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
20/05/2025
Patient information leaflet
Français
20/05/2025
Patient information leaflet
Italien
20/05/2025
Summary of Product Characteristics
Allemand
20/05/2025
Summary of Product Characteristics
Français
20/05/2025
Summary of Product Characteristics
Italien
20/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance WIZUS
(N/A)
17.7 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Authorization holder

Daiichi Sankyo (Schweiz) AG

8048 Zürich

Authorization information

Swissmedic authorization number
69710
Drug name
VANFLYTA, Filmtabletten
Galenic form
FILM
ATC Code
L01EX11
Authorization status
Z
Dispensing category
A
First authorization
31/03/2025
Authorization expiration date
30/03/2030
IT Number
07.16.1.
Domain
Human medicine
Field of application
Erwachsene Patienten mit akuter myeloischer Leukämie (AML), die FLT3-ITD-positiv ist

Package details

Description (FR)
VANFLYTA cpr pell 17.7 mg 28 pce
Description (DE)
VANFLYTA Filmtabl 17.7 mg 28 Stk
Market launch
31/03/2025
Narcotic (BTM)
No

Other package sizes (4)

None
14 TABL
GTIN: None
Not in V1
None
14 TABL
GTIN: None
Not in V1
None
28 TABL
GTIN: None
Not in V1
VANFLYTA cpr pell 26.5 mg 56 pce
56 TABL
GTIN: 7680697100059
View